Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 8/20 | 0.64 |
| ▸ | CYP1B1 | Q16678 | 8/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | NQO2 | P16083 | 6/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.52 |
| ▸ | ABL1 | P00519 | 3/20 | 0.52 |
| ▸ | BCR | P11274 | 3/20 | 0.52 |
| ▸ | TTR | P02766 | 3/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.52 |
| ▸ | ESR1 | P03372 | 2/20 | 0.52 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.52 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.52 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.52 |
| ▸ | TUBB | P07437 | 1/20 | 0.52 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.52 |
| ▸ | AHR | P35869 | 1/20 | 0.52 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.52 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.52 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methoxymethane SCHEMBL28654805 | 0.97 | CYP1A1 (0.61) | CYP1A1CYP1B1ALDH1A1NQO2CYP1A2 | |
| SCHEMBL25195786 | 0.95 | CYP1A1 (0.56) | CYP1A1CYP1B1ALDH1A1NQO2CYP1A2 | |
| SCHEMBL31618743 | 0.86 | CYP1A1 (0.48) | CYP1A1CYP1B1ALDH1A1NQO2CYP1A2 | |
| SCHEMBL9928608 | 0.86 | CYP1A1 (0.58) | CYP1A1CYP1B1ALDH1A1NQO2CYP1A2 | |
| SCHEMBL12662829 | 0.86 | CYP1A1 (0.48) | CYP1A1CYP1B1ALDH1A1NQO2CYP1A2 | |
| SCHEMBL19892915 | 0.85 | CYP1A1 (0.48) | CYP1A1CYP1B1ALDH1A1NQO2CYP1A2 | |
| SCHEMBL16954499 | 0.85 | ESR1 (0.59) | CYP1A1CYP1B1ALDH1A1NQO2CYP1A2 | |
| SCHEMBL27786572 | 0.85 | ESR1 (0.59) | CYP1A1CYP1B1ALDH1A1NQO2CYP1A2 | |
| SCHEMBL16961093 | 0.84 | NQO2 (0.48) | CYP1A1CYP1B1ALDH1A1NQO2CYP1A2 | |
| SCHEMBL16956942 | 0.84 | AHR (0.48) | CYP1A1CYP1B1ALDH1A1NQO2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113061203-B | Catalyst and preparation method thereof, and preparation method of styrene monomer isotactic polymer | 中国科学院长春应用化学研究所 | 2022-03-29 | — | — | CN | claimed |
| CN-113061203-A | Catalyst and preparation method thereof, and preparation method of styrene monomer isotactic polymer | 中国科学院长春应用化学研究所 | 2021-07-02 | — | — | CN | claimed |
| CN-103387636-B | Containing film-forming resin and the positivity 248nm photoresist material thereof of sesquiterpene | KUNSHAN SD PHOTOELECTRIC MATERIAL CO., LTD. (CN) | 2015-08-12 | — | — | CN | claimed |
| CN-104387512-A | Sesquiterpene-containing film forming resin and negative 248nm photoresist thereof | KUNSHAN XIDI OPTOELECTRONIC MATERIAL CO LTD | 2015-03-04 | — | — | CN | claimed |
| CN-103387636-A | Sesquiterpene-containing film-forming resin and positive 248 nm photoresist thereof | KUNSHAN SD PHOTOELECTRIC MATERIAL CO LTD | 2013-11-13 | — | — | CN | claimed |
| CN-101544591-B | (E)-substituted styrene compound and preparation method thereof | UNIV HEBEI SCIENCE & TECH | 2013-07-10 | — | — | CN | claimed |
| CN-102050908-A | Chemical amplitude-increasing type silicon-containing I-line ultraviolet negative photoresist and forming resin thereof | KUNSHAN XIDI OPTOELECTRONIC MATERIAL CO LTD | 2011-05-11 | — | — | CN | claimed |
| CN-101974121-A | Chemical amplified high-resolution silicon-containing I-ray ultraviolet photoresist and forming resin thereof | KUNSHAN XIDI ELECTRO OPTIC MATERIALS CO LTD | 2011-02-16 | — | — | CN | claimed |
| EP-1130017-B1 | Azole derivatives and their use as superoxide radical inhibitors | OTSUKA PHARMA CO LTD (JP) | 2005-06-15 | — | — | EP | claimed |
| US-12404221-B2 | Methods of arene alkenylation | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2025-09-02 | — | — | US | disclosed |
| CN-120136646-A | Method for synthesizing benzyl alkyl ketone compound by visible light catalysis | 中国科学院化学研究所 | 2025-06-13 | — | — | CN | disclosed |
| CN-119219575-B | Antitumor cinnamyl piperazine resveratrol conjugate or pharmaceutically acceptable salt thereof, and preparation method and application thereof | 天津科技大学 | 2025-03-11 | — | — | CN | disclosed |
| CN-119219575-A | Antitumor cinnamyl piperazine resveratrol conjugate or pharmaceutically acceptable salt thereof, and preparation method and application thereof | 天津科技大学 | 2024-12-31 | — | — | CN | disclosed |
| CN-118852077-A | Coumarin derivatives with breast cancer resisting activity and application thereof | 常州大学 | 2024-10-29 | — | — | CN | disclosed |
| US-5661153-A | FOR TREATING ALLERGIES, ASTHMA, DERMATITIS, GRAFT REJECTIONS | JAPAN ENERGY CORPORATION (JP) | 1997-08-26 | — | — | US | disclosed |
| US-5643932-A | PREVENTS CELL DAMAGE AFTER ISCHEMIA AND RE-PERFUSION, SUBSTITUTED THIAZOLES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1997-07-01 | — | — | US | disclosed |
| US-5510434-A | Catalyst for producing aromatic vinyl compound polymer and process for producing aromatic vinyl compound polymer by using same | IDEMITSU KOSAN CO., LTD. (JP) | 1996-04-23 | — | — | US | disclosed |
| EP-0700908-A1 | 1-Arylpyrimidine derivatives and pharmaceutical use thereof | JAPAN ENERGY CORPORATION (JP) | 1996-03-13 | — | — | EP | disclosed |
| EP-0655467-A1 | Catalyst for producing aromatic vinyl compound polymer and process for producing aromatic vinyl compound polymer by using same | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1995-05-31 | — | — | EP | disclosed |
| EP-0513387-A1 | ACTIVE OXYGEN INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-11-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12404221-B2 | Methods of arene alkenylation | CYBB, CBR3, AHR | CYP1A1 90/4885CYP1B1 62/4885ALDH1A1 414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.